Wei Ping Qian Selected Research

1- ((N- (2,3,4,5,6- pentafluorocinnamoyl)- O- (2,6- dichlorobenzyl))tyrosyl)- 4- (bis(diethoxyphosphono))methylaminiopiperidine

10/2008

BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Ping Qian Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 09/2008
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 09/2008
3	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018 - 03/2013
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2018
1	Body Weight (Weight, Body) 11/2018
1	Breast Neoplasms (Breast Cancer) 11/2018
1	Colonic Neoplasms (Colon Cancer) 11/2018
1	Residual Neoplasm 03/2013

Drug/Important Bio-Agent (IBA)

2	Prostate-Specific Antigen (Semenogelase)IBA 10/2008 - 09/2008
1	plerixafor FDA Link 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Interleukin-11 (Interleukin 11)IBA 01/2021
1	UBS109IBA 11/2018
1	CurcuminIBA 11/2018
1	Pharmaceutical PreparationsIBA 03/2013
1	Gemcitabine FDA Link 03/2013
1	Therapeutic UsesIBA 03/2013
1	Urokinase Plasminogen Activator ReceptorsIBA 03/2013
1	1- ((N- (2,3,4,5,6- pentafluorocinnamoyl)- O- (2,6- dichlorobenzyl))tyrosyl)- 4- (bis(diethoxyphosphono))methylaminiopiperidineIBA 10/2008
1	Tyrosine (L-Tyrosine)FDA Link 10/2008
1	SurvivinIBA 10/2008
1	Diphosphonates (Bisphosphonates)IBA 10/2008
1	AmidesIBA 10/2008
1	AntibodiesIBA 09/2008
1	Androgen Receptors (Androgen Receptor)IBA 09/2008

Therapy/Procedure

2	Therapeutics 01/2021 - 03/2013
1	Intraperitoneal Injections 11/2018
1	Drug Therapy (Chemotherapy) 03/2013
1	Precision Medicine 03/2013
1	Aftercare (After-Treatment) 10/2008